• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

Ethyl 4-methylidenecyclohexane-1-carboxylate (CAS No. 145576-28-9): A Comprehensive Overview in Modern Chemical Biology

Ethyl 4-methylidenecyclohexane-1-carboxylate (CAS No. 145576-28-9) is a significant compound in the realm of chemical biology, characterized by its unique structural and functional attributes. This molecule, featuring a cyclohexane core with an ester group and a methylidene substituent, has garnered attention for its potential applications in pharmaceutical research and synthetic chemistry. The detailed exploration of its properties, synthesis methods, and emerging applications in biomedical research provides a comprehensive understanding of its relevance in contemporary scientific endeavors.

The molecular structure of Ethyl 4-methylidenecyclohexane-1-carboxylate exhibits a blend of flexibility and rigidity, which is pivotal for its biological interactions. The cyclohexane ring provides a stable scaffold, while the ester functionality enhances solubility and reactivity, making it a versatile intermediate in organic synthesis. Furthermore, the presence of the methylidene group introduces electronic and steric effects that can modulate the compound's behavior in various biochemical pathways.

In recent years, there has been a surge in research focused on the development of novel pharmacophores derived from cyclohexane derivatives. Ethyl 4-methylidenecyclohexane-1-carboxylate has emerged as a promising candidate due to its ability to mimic natural products and bioactive molecules. Studies have demonstrated its potential in inhibiting specific enzymes and receptors, which are implicated in various diseases. For instance, preliminary investigations suggest that this compound may exhibit anti-inflammatory properties by interacting with cyclooxygenase enzymes, thereby offering a new avenue for therapeutic intervention.

The synthesis of Ethyl 4-methylidenecyclohexane-1-carboxylate involves multi-step organic reactions that highlight the compound's synthetic utility. Traditional methods often employ Grignard reactions or condensation reactions to introduce the methylidene functionality. However, recent advancements in catalytic processes have enabled more efficient and sustainable synthetic routes. For example, transition metal-catalyzed cross-coupling reactions have been optimized to achieve higher yields and purity, reducing the environmental impact of production.

One of the most intriguing aspects of Ethyl 4-methylidenecyclohexane-1-carboxylate is its role as a building block in drug discovery. The structural motifs present in this compound can be modified to create libraries of derivatives with tailored biological activities. High-throughput screening techniques combined with computational modeling have accelerated the identification of lead compounds derived from this scaffold. This approach has been particularly effective in targeting complex diseases such as cancer and neurodegenerative disorders, where precise molecular interactions are crucial for therapeutic efficacy.

The pharmacokinetic profile of Ethyl 4-methylidenecyclohexane-1-carboxylate is another area of active investigation. Understanding how the compound is absorbed, distributed, metabolized, and excreted (ADME) is essential for optimizing its clinical application. Preclinical studies have begun to unravel these processes, providing insights into potential dosing regimens and formulation strategies. For instance, modifications to the ester group have been explored to enhance bioavailability and reduce metabolic clearance.

The future prospects for Ethyl 4-methylidenecyclohexane-1-carboxylate are vast, driven by ongoing research and technological innovations. As computational chemistry advances, virtual screening methods will become more sophisticated, allowing researchers to predict the biological activity of novel derivatives with greater accuracy. Additionally, green chemistry principles are being integrated into synthetic protocols to minimize waste and energy consumption. These efforts align with global initiatives to promote sustainable pharmaceutical development.

In conclusion, Ethyl 4-methylidenecyclohexane-1-carboxylate (CAS No. 145576-28-9) represents a cornerstone in modern chemical biology. Its unique structural features make it a valuable tool for drug discovery and synthetic chemistry. As research continues to uncover new applications and optimize production methods, this compound is poised to play an increasingly important role in addressing some of the most pressing challenges in medicine today.

• 138125-21-0(15-Acetoxylabd-8(17)-en-19-carbonsaeure)
• 18318-71-3(N/A)
• 63649-25-2(diethyl trans-4-methylene-1,2-cyclopentanedicarboxylate)
• 99769-56-9([(4-methylenecyclohexyl)methyl] hydrogen succinate)
• 18318-70-2(15-Acetoxylabd-8(17)-en-19-carbonsaeure)
• 76803-33-3(4-Pentenoic acid, 2,4-dimethyl-2-(2-propenyl)-, ethyl ester)
• 90646-75-6(4-Pentenoic acid, 2,4-dimethyl-, ethyl ester)
• 5095-37-4(N/A)
• 138-23-8(Propanoic acid,2-methyl-, 3,7-dimethyl-7-octen-1-yl ester)
• 76803-34-4(5-Hexenoic acid, 2,5-dimethyl-2-(2-propenyl)-, ethyl ester)